FIRST RUSSIAN EXPERIENCE OF USING CONTRAST-ENHANCED INTRAOPERATIVE ULTRASONOGRAPHY (CE-IOUS) IN THE TREATMENT OF LIVER LESIONS

For today it is difficult to imagine medical practice without modern visualization methods of instrumental diagnostics. At the same time, according to the estimates of the World Health Organization, two-thirds of the world population is deprived of such opportunities. Ultrasound diagnostics with intravenous contrasting (CEUS), which requires minimal financial costs and technical equipment, has a great potential to remedy this situation. At present, there is a growing interest in the use of echography with contrast enhancement in order to improve the efficiency of detecting focal pathology and the accuracy of differential diagnosis, incl. in surgical hepatology.

Difficulties in planning the surgical tactics in patients with metastatic colorectal liver cancer are well known (discrepancy in the data of preoperative methods of radiation diagnosis about the number and segmental location of foci in the liver, the probability of additional foci). The “gold standard” of the diagnostic evaluation, which combines palpation of the liver and the performance of intraoperative ultrasound (IOUS), is now supplemented by the possibility of contrast enhancement during intraoperative echography.

In this article, we present a description of the method of ultrasound diagnostics with intravenous (IV) contrasting, illustrating the possibilities of investigation by clinical cases of intraoperative ultrasound diagnostics with contrast enhancement in patients with metastatic liver cancer.

Our impressions about the possibilities of ultrasound with intravenous contrast in the intraoperative diagnosis of tumor foci in patients with metastatic liver cancer we build on this little experience.

1. Greis C. Technological review: contrast-enhanced ultrasonography. Contrast enhanced ultrasound modality: the new diagnostic imaging tool, p. 1–5, Springer Press 2008, ISBN 978–88–470–0781–9

2. Westwood M, Joore M, Grutters J, Redekop K, Armstrong N, Lee K, et al. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2013 Apr;17 (16):1–243. DOI: 10.3310/hta17160

3. Stepanov SO, Mitina LA, Kazakevich VI, Kaprin AD, Alekseev BYa, Kostin AA, et al. Ul’trazvukovaya diagnostika ochagovykh obrazovanii v pecheni s ispol’zovaniem kontrastnogo preparata Sonov’yu. Meditsinskaya tekhnologiya [Ultrasonic diagnostics of focal formations in the liver using the contrast drug Sonoview. Medical technology]. Мoscow, 2015. (In Russian).

4. Claudon M., Cosgrove D., Albrecht T, Bolondi L, Bosio M, Calliada F, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) — Update 2008. Ultraschall Med. 2008 Feb;29 (1):28–44. DOI: 10.1055/s-2007–963785

5. Tamandl D, Herberger B, Gruenberger B, Schoppmann SF, Puhalla H, Schindl M, et al. Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. Surgery. 2008 May;143 (5):648–57. DOI: 10.1016/j.surg.2007.11.020

6. Trillaud H, Bruel JM, Valette PJ, Vilgrain V, Schmutz G, Oyen R, et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol. 2009 Aug 14;15 (30):3748–56.

7. Ruzzenente A, Conci S, Iacono C, Valdegamberi A, Campagnaro T, Bertuzzo F, et al. Usefulness of Contrast-Enhanced Intraoperative Ultrasonography (CE-IOUS) in Patients with Colorectal Liver Metastases after Preoperative Chemotherapy. J Gastrointest Surg. 2013 Feb;17 (2):281–7. DOI: 10.1007/s11605–012–2043-y

8. Dietrich CF, Kratzer W, Strobel D, Danse E, Fessl R, Bunk A, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol. 2006 Mar 21;12 (11):1699–705. DOI: 10.3748/wjg.v12.i11.1699